Upload Avatar (500 x 500)
Leming Shi
lemingshi@fudan.edu.cn
English, Chinese
Shanghai
Fudan University
Life Sciences
  • 1985 - Bachelor's Degree in Analytical Chemistry: Hunan University
  • 1988 - Master's Degree in Computational Chemistry: University of Science and Technology of China
  • 1991 - Ph.D. in Computational Chemistry: Institute of Process Engineering, Chinese Academy of Sciences
  • Published over 200 papers, including 15 in Nature Biotechnology
  • h-index of 55 with over 13,000 citations
  • Co-authored the book 'Big Data and Precision Medicine' (2017)
  • Co-founded the International MAQC Society and served as its first president (2017-2018)
  • 1991-1993 - Assistant Researcher: Institute of Process Engineering, Chinese Academy of Sciences
  • 1993-1994 - Associate Researcher: Institute of Process Engineering, Chinese Academy of Sciences
  • 1994-1997 - Postdoctoral Researcher: Case Western Reserve University and NIH/NCI
  • 1997-2001 - Various roles: FDA, Wyeth, and BASF in the USA
  • 2001 - Co-founder: Shenzhen Chipscreen Biosciences
  • 2003 - Rejoined FDA: Initiated MAQC/SEQC
  • 2011 - Joined Fudan University: Professor at School of Life Sciences, Human Phenome Institute, and affiliated Cancer Hospital
  • 2017 - Chinese Patent Gold Award (4th contributor)
  • 2019 - Chief Scientist of National Key R&D Program 'Strategic International Scientific and Technological Innovation Cooperation'
Chemical Genomics
Pharmacogenomics
Precision Medicine
Medical Big Data
Bioinformatics
Cheminformatics
  • Towards best practice in cancer mutation detection with whole-genome and whole-exome sequencing, Xiao W, Ren L, ..., Wang C, Shi L, 2021
  • Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing, Fang LT, Zhu B, Zhao Y, ..., Hong H, Shi L, Wang C, Xiao W, 2021
  • Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies, Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, ..., Wang P, Shi L, Huang W, Shao ZM, 2019
  • The international MAQC Society launches to enhance reproducibility of high-throughput technologies, Shi L, ..., Tong W, 2017
  • Telomerase activation by genomic rearrangements in high-risk neuroblastoma, Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, ..., Shi L, ..., Westermann F, Thomas RK, Fischer M, 2015
  • A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequence Quality Control consortium, Su Z, Łabaj PP, Li S, ..., Kreil DP, Mason CE, Shi L, 2014
  • The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models, Shi L, ..., Wolfinger RD, 2010
  • Evaluation of external RNA controls for the assessment of microarray performance, Tong W, ..., Shi L, 2006
  • Rat toxicogenomic study reveals analytical consistency across microarray platforms, Guo L, ..., Shi L, 2006
  • The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements, Shi L, ..., Slikker W, Jr, 2006
Chemical Genomics Pharmacogenomics Precision Medicine Medical Big Data Bioinformatics Cheminformatics Biomarkers Disease Prevention Diagnosis Treatment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.